Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
Journal of Clinical Medicine
|
October 16, 2024
Estetrol Inhibits the Prostate Cancer Tumor Stimulators FSH and IGF-1
Herjan J T Coelingh Bennink, Erik P M Roos, R Jeroen A van Moorselaar, et al.
Endocrine Connections
|
October 25, 2022
Maintaining bone health by estrogen therapy in patients with advanced prostate cancer: a narrative review
Herjan J T Coelingh Bennink, Jan Krijgh, Jan F M Egberts, et al.
BJU International
|
July 14, 2016
Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men
Frans M J Debruyne, Hermann M Behre, Claus G Roehrborn, et al.
European Urology Open Science
|
November 10, 2022
Estetrol Prevents Hot Flushes and Improves Quality of Life in Patients with Advanced Prostate Cancer Treated with Androgen Deprivation Therapy: The PCombi Study
Yvette Zimmerman, Mark Frydenberg, Hendrik van Poppel, et al.
European Urology Open Science
|
August 2, 2021
Estetrol Cotreatment of Androgen Deprivation Therapy in Infiltrating or Metastatic, Castration-sensitive Prostate Cancer: A Randomized, Double-blind, Phase II Trial (PCombi)
Herjan J T Coelingh Bennink, Jeroen A van Moorselaar, E David Crawford, et al.
The Lancet. Oncology
|
December 24, 2016
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial
Abdel-Rahmène Azzouzi, Sébastien Vincendeau, Eric Barret, et al.
The Journal of Sexual Medicine
|
August 8, 2017
Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME)
Raymond C Rosen, Frederick Wu, Hermann M Behre, et al.
International Journal of Impotence Research
|
June 12, 2002
A shared care approach to the management of erectile dysfunction in the community
G Wagner, H Claes, P Costa, et al.
Thescientificworldjournal
|
April 2, 2014
Cochlear implant programming: a global survey on the state of the art
Bart Vaerenberg, Cas Smits, Geert De Ceulaer, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
Journal of Clinical Medicine
|
October 16, 2024
Estetrol Inhibits the Prostate Cancer Tumor Stimulators FSH and IGF-1
Herjan J T Coelingh Bennink, Erik P M Roos, R Jeroen A van Moorselaar, et al.
Endocrine Connections
|
October 25, 2022
Maintaining bone health by estrogen therapy in patients with advanced prostate cancer: a narrative review
Herjan J T Coelingh Bennink, Jan Krijgh, Jan F M Egberts, et al.
BJU International
|
July 14, 2016
Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men
Frans M J Debruyne, Hermann M Behre, Claus G Roehrborn, et al.
European Urology Open Science
|
November 10, 2022
Estetrol Prevents Hot Flushes and Improves Quality of Life in Patients with Advanced Prostate Cancer Treated with Androgen Deprivation Therapy: The PCombi Study
Yvette Zimmerman, Mark Frydenberg, Hendrik van Poppel, et al.
European Urology Open Science
|
August 2, 2021
Estetrol Cotreatment of Androgen Deprivation Therapy in Infiltrating or Metastatic, Castration-sensitive Prostate Cancer: A Randomized, Double-blind, Phase II Trial (PCombi)
Herjan J T Coelingh Bennink, Jeroen A van Moorselaar, E David Crawford, et al.
The Lancet. Oncology
|
December 24, 2016
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial
Abdel-Rahmène Azzouzi, Sébastien Vincendeau, Eric Barret, et al.
The Journal of Sexual Medicine
|
August 8, 2017
Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME)
Raymond C Rosen, Frederick Wu, Hermann M Behre, et al.
International Journal of Impotence Research
|
June 12, 2002
A shared care approach to the management of erectile dysfunction in the community
G Wagner, H Claes, P Costa, et al.
Thescientificworldjournal
|
April 2, 2014
Cochlear implant programming: a global survey on the state of the art
Bart Vaerenberg, Cas Smits, Geert De Ceulaer, et al.
Page
of 8